Simultaneous determination of atorvastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

作者: Vasu Babu Ravi , Ramesh Mullangi , Jaswanth Kumar Inamadugu , Nageswara Rao Pilli , Ramakrishna Gajula

DOI: 10.1002/BMC.2715

关键词:

摘要: A rapid, simple, sensitive and selective LC-MS/MS method has been developed validated for quantification of the atorvastatin (AT) niacin (NA) in 250 μL human plasma. The analytical procedure involves a liquid–liquid extraction using nevirapine as an internal standard (IS). chromatographic separation was achieved on Hypurity Advance (4.6 × 50 mm, 5 µm) column mobile phase consisting 0.1% formic acid buffer–acetonitrile (20:80, v/v) at flow rate 0.8 mL/min. API-4000 operated multiple-reaction monitoring mode electrospray ionization. total run time analysis 3 min elution AT, NA IS occurred 1.06, 1.84 0.92 min, respectively. detailed validation performed per US Food Drug Administration guidelines curves found to be linear range 0.10–30.0 ng/mL AT 20.2–6026 ng/mL NA, with coefficient correlation ≥0.99 both compounds. were stable battery stability studies, viz. bench-top, autosampler, re-injection, wet-extract repeated freeze–thaw cycles. assay successfully applied pharmacokinetic study humans. Copyright © 2012 John Wiley & Sons, Ltd.

参考文章(24)
Bhavesh Dasandi, Ashutosh J Jani, Anita A Mehta, Shivprakash Rathnam, Liquid Chromatographic-MS/ MS Determination of Atorvastatin and Metabolites in Human Plasma Eurasian Journal of Analytical Chemistry. ,vol. 5, pp. 46- 52 ,(2010)
S. Tavintharan, Moti L. Kashyap, The benefits of niacin in atherosclerosis. Current Atherosclerosis Reports. ,vol. 3, pp. 74- 82 ,(2001) , 10.1007/S11883-001-0014-Y
Kishor S. Jain, M.K. Kathiravan, Rahul S. Somani, Chamanlal J. Shishoo, The biology and chemistry of hyperlipidemia Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 4674- 4699 ,(2007) , 10.1016/J.BMC.2007.04.031
Jingduan Chi, Anura L Jayewardene, Judith A Stone, Francesca T Aweeka, An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma. Journal of Pharmaceutical and Biomedical Analysis. ,vol. 31, pp. 953- 959 ,(2003) , 10.1016/S0731-7085(02)00708-2
Lucie Nováková, Hana Vlčková, Dalibor Šatínský, Petr Sadílek, Dagmar Solichová, Milan Bláha, Vladimír Bláha, Petr Solich, Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin. Journal of Chromatography B. ,vol. 877, pp. 2093- 2103 ,(2009) , 10.1016/J.JCHROMB.2009.05.052
V. Bořek-Dohalský, J. Huclová, B. Barrett, B. Němec, I. Ulč, I. Jelínek, Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma- : pharmacokinetic study Analytical and Bioanalytical Chemistry. ,vol. 386, pp. 275- 285 ,(2006) , 10.1007/S00216-006-0655-3
John R. Guyton, Combination drug therapy for combined hyperlipidemia. Current Cardiology Reports. ,vol. 1, pp. 244- 250 ,(1999) , 10.1007/S11886-999-0030-Z
Ramakrishna V. S. Nirogi, Vishwottam N. Kandikere, Manoj Shukla, Koteshwara Mudigonda, Santosh Maurya, Ravikumar Boosi, Yerramilli Anjaneyulu, Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography–tandem mass spectrometry using rosuvastatin as internal standard Biomedical Chromatography. ,vol. 20, pp. 924- 936 ,(2006) , 10.1002/BMC.622